Dendrimer-Based Nanomedicine
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Nanomedicine and Nanotechnology".
Deadline for manuscript submissions: closed (20 November 2020) | Viewed by 14530
Special Issue Editor
Interests: nanomedicine; drug delivery; nanoparticles; biological systems
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
In the past decades, dendrimers have gained popularity in the field of nanomedicine. Dendrimers are polymeric molecules with a well-defined shape and size that can successfully be used in gene therapy, medical imaging, and immunology, which are used primarily as nanocarriers for the delivery of drugs or genes to target cells. Dendrimers are more efficient than liposomes, linear polymers, or viral vectors in transferring of many kinds of biomolecules. In this regard, the mechanisms of interaction between dendrimers and biological systems have now become of significant interest, with an abundance of articles now being reported in the literature.
For this Special Issue, we invite submissions of manuscripts focusing on the dendritic nanoparticles that could be applied in biomedicine as new nanotherapeutic agents, especially in the field of drug and gene delivery.
Prof. Maksim Ionov
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Dendrimer
- Dendriplex
- Drug carrier
- Gene delivery
- Interaction
- Antiviral
- Toxicity
- Targeting delivery
- Biomedicine
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.